The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Yuki Endo
Honoraria - Bristol-Myers Squibb; Merck; MSD; Nippon Kayaku; Ono Pharmaceutical
 
Yuma Sakura
No Relationships to Disclose
 
Go Kaneko
No Relationships to Disclose
 
Nozomi Hayakawa
No Relationships to Disclose
 
Daiki Ikarashi
No Relationships to Disclose
 
Ryo Yamashita
No Relationships to Disclose
 
Suguru Shirotake
No Relationships to Disclose
 
Wataru Obara
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb Japan; Merck; MSD; Ono Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Asahi Kasei (Inst); Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Takeda (Inst)
 
Yukihiro Kondo
No Relationships to Disclose
 
Eiji Kikuchi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Chugai Pharma; Ferring; Janssen; Merck; MSD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Chugai Pharma; Eisai; Ferring; Janssen; Kissei Pharmaceutical; Kyorin; Merck; MSD; Nippon Kayaku; Sanofi; Taiho Pharmaceutical; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); Janssen (Inst); Kyorin (Inst); Kyowa Kirin International (Inst); Merck (Inst); MSD (Inst); Nihonkayaku (Inst); Nippon Shinyaku (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Merck